Search research articles
Contact Us
Filters
Showing results (171-180 of 229) with videos related to
Page
of 23
Sort By:
Annals of Surgical Oncology
|
December 18, 2012
Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface
Elizabeth H Baldini, Michelle R Lapidus, Qian Wang, et al.
Clinical Sarcoma Research
|
March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)
Michael C Heinrich, Janice Patterson, Carol Beadling, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Annals of Surgical Oncology
|
May 29, 2015
Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists
Elizabeth H Baldini, Walter Bosch, John M Kane, et al.
The American Journal of Surgical Pathology
|
January 15, 2026
Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Bibianna Purgina, Elena Di Blasi, Paola Collini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
Matthew L Hemming, Patrick Bhola, Michael A Loycano, et al.
Molecular Cancer Therapeutics
|
August 28, 2022
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
William A Blessing, Christopher S Digesu, Rong Liu, et al.
Nature
|
November 1, 2019
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
William A Flavahan, Yotam Drier, Sarah E Johnstone, et al.
Annals of Surgery
|
September 27, 2023
New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter
Dario Callegaro, Francesco Barretta, Chandrajit P Raut, et al.
Immunity
|
February 24, 2017
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George, Diana Miao, George D Demetri, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 229) with videos related to
Sort By:
Page
of 23
Annals of Surgical Oncology
|
December 18, 2012
Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface
Elizabeth H Baldini, Michelle R Lapidus, Qian Wang, et al.
Clinical Sarcoma Research
|
March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)
Michael C Heinrich, Janice Patterson, Carol Beadling, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2010
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors
George D Demetri, Margaret von Mehren, Cristina R Antonescu, et al.
Annals of Surgical Oncology
|
May 29, 2015
Retroperitoneal sarcoma (RPS) high risk gross tumor volume boost (HR GTV boost) contour delineation agreement among NRG sarcoma radiation and surgical oncologists
Elizabeth H Baldini, Walter Bosch, John M Kane, et al.
The American Journal of Surgical Pathology
|
January 15, 2026
Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
Bibianna Purgina, Elena Di Blasi, Paola Collini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 24, 2022
Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression
Matthew L Hemming, Patrick Bhola, Michael A Loycano, et al.
Molecular Cancer Therapeutics
|
August 28, 2022
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death
William A Blessing, Christopher S Digesu, Rong Liu, et al.
Nature
|
November 1, 2019
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
William A Flavahan, Yotam Drier, Sarah E Johnstone, et al.
Annals of Surgery
|
September 27, 2023
New Sarculator Prognostic Nomograms for Patients With Primary Retroperitoneal Sarcoma: Case Volume Does Matter
Dario Callegaro, Francesco Barretta, Chandrajit P Raut, et al.
Immunity
|
February 24, 2017
Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
Suzanne George, Diana Miao, George D Demetri, et al.
Page
of 23